ARCHIVES

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

This article is from The Cancer Letter archive.

Vol. 06 No. 17 | April 25, 1980

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Coalitions Diverge On NIH Role, Agree On Need For More Basic Research

February 19, 1993

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

February 24, 2012

Black, Hispanic Cancer Initiatives to Be Funded, Formed

June 7, 1991